Capricor Therapeutics | CAPR - Cash And Equivalent


Capricor Therapeutics reported $20.94M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Bioline Rx USD 2.5M 5.41M Mar/2026
Capricor Therapeutics USD 20.94M 84.49M Jun/2026
Cipla INR 10.18B 2.22B Mar/2026
Cytokinetics USD 255.27M 125.43M Jun/2026
Geron USD 62.64M 6.25M Jun/2026
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 186.63M 171.15M Mar/2026
J&J USD 20.42B 1.27B Jun/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
Prothena USD 288.19M 41.27M Jun/2026
PTC Therapeutics USD 1.05B 215.9M Jun/2026
Sarepta Therapeutics USD 571.15M 106.7M Jun/2026